• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet: Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people

Mary Wilson

Well-known member
Published: February 10, 2021
DOI: https://doi.org/10.1016/S2352-4642(21)00030-4


Sarah Brookman, James Cook, Mark Zucherman, Simon Broughton, Katharine Harman, Atul Gupta

The clinical impact of the new SARS-CoV-2 lineage B.1?1.7 on children and young people (aged 18 years or younger) regarding acute respiratory COVID-19 is yet to be fully defined. Media reports of increases in admissions to hospital and more serious illness in children and young people have resulted in public confusion and implicated the B.1.1.7 variant as a more pathogenic infection within this group.[SUP]1[/SUP][SUP], [/SUP][SUP]2[/SUP] This uncertainty has necessitated a public statement from the Royal College of Paediatrics and Child Health.[SUP]3[/SUP]

It is important to rapidly clarify the true impact of the second wave on children and young people within the context of a high prevalence of the B.1.1.7 variant, estimated to account for 70% of infections in the London region in January, 2021.[SUP]4

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00030-4/fulltext
[/SUP]
 
Back
Top Bottom